For example, patients with T1DM and some of those with latent autoimmune diabetes of the adult (LADA) must be treated with continuous subcutaneous insulin infusion (CSII) or with multiple daily injection (MDI) regimens of fixed insulin doses or insulin doses conditioned to carbohydrate counting (9). The gene discussed is INS; the disease is type 1 diabetes mellitus.